PlainRecalls
FDA Devices Moderate Class II Ongoing

GORE CARDIOFORM Septal Occluder, REF: GSX0030A

Reported: February 8, 2023 Initiated: December 14, 2022 #Z-1048-2023

Product Description

GORE CARDIOFORM Septal Occluder, REF: GSX0030A

Reason for Recall

Septal Occluders released with incomplete quality test documentation that assesses the release of the device from the delivery system during the index procedure. A potential failure of this quality test could potentially result could result in occluder embolization, anoxic brain injury, central venous or arterial perforation or rupture.

Details

Units Affected
14
Distribution
US Nationwide distribution in the states of NY, CA, FL, CT, TX, AR, IN, MA, MO, SD, VA.
Location
Flagstaff, AZ

Frequently Asked Questions

What product was recalled?
GORE CARDIOFORM Septal Occluder, REF: GSX0030A. Recalled by W L Gore & Associates, Inc.. Units affected: 14.
Why was this product recalled?
Septal Occluders released with incomplete quality test documentation that assesses the release of the device from the delivery system during the index procedure. A potential failure of this quality test could potentially result could result in occluder embolization, anoxic brain injury, central venous or arterial perforation or rupture.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 8, 2023. Severity: Moderate. Recall number: Z-1048-2023.